Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Bee propolis has been studied for its potential role in treating herpes simplex virus (HSV) infections, particularly cold sores (HSV-1). Several in vitro studies have shown that propolis extracts can inhibit HSV replication. A few small human clinical trials have investigated topical propolis preparations for oral or genital herpes outbreaks. For example, a randomized controlled trial published in Phytomedicine (2010) found that a 3% propolis ointment was more effective than both acyclovir and placebo in healing genital herpes lesions, with faster healing times and reduced symptoms. Another trial suggested similar benefits for labial herpes. The proposed mechanisms include antiviral effects, anti-inflammatory action, and immune modulation, attributed to flavonoids and phenolic acids in propolis.

However, despite these promising findings, the evidence base is limited by the small number and size of clinical trials, heterogeneity in propolis composition, and lack of large-scale, high-quality studies. While propolis is used traditionally in several cultures for wound healing and infections, its application specifically for herpes has been driven primarily by modern research rather than historical use. In summary, there is moderate scientific evidence (rating: 3/5) supporting topical bee propolis as an adjunctive treatment for herpes lesions, but it cannot yet be recommended as a replacement for conventional antiviral therapy.

More about Bee Propolis
More about Herpes

Other ingredients used for Herpes

Other health conditions supported by Bee Propolis

Products containing Bee Propolis